Past event: CRISPR 2016 Conference

Unlocking the True Potential of CRISPR Cas9 Gene Editing!

Europe's #1 event for addressing CRISPR's application challenges

AstraZeneca and Novartis have turned to CRISPR for drug discovery, have you?

2015 has seen an increasing percentage of pharmaceutical companies implement CRISPR technologies into their drug discovery plans.

Earlier this year Novartis' Institute for BioMedical Research (NIBR) President Mark Fishman stated "we have glimpsed the power of CRISPR tools in our scientific programs in NIBR, and it is now time to explore how to safely extend this powerful technology to the clinic."

AstraZeneca have announced four research collaborations aimed at harnessing the power of CRISPR, and GlaxoSmithKline is leading a $64 million investment for CRISPR Therapeutics.

There is no doubt about it, CRISPR is rapidly changing the way diseases are researched, and will soon revolutionise the way they are treated.

Whether you are already underway with using CRISPR in your research, or are considering implementing the technology, this conference will provide you with all the information you need to harness CRISPR's true potential.

We are bringing together key industry leaders to introduce you to the CRISPR revolution, and help you address the specificity, efficiency and delivery challenges preventing you from making the most of the CRISPR technology.


Don't miss out on:

  • A keynote address from the Zhang Lab's Jonathan Gootenberg, who will share his experience working with Feng Zhang to discover the Cpf1 protein, and what this discovery means for the future of gene editing
  • Discovering the latest tools, technologies and techniques in CRISPR application from the Doudna Lab's Sam Sternberg, who has been working closely with Jennifer Doudna to optimize the CRISPR technique
  • Learning how to rapidly and accurately identify drug targets with true potential from experts from AstraZeneca who are using CRISPR in drug discovery and screening
  • Discovering how Takeda are using CRISPR to stimulate homologous recombination for driving large genome alterations in recalcitrant cell lines
  • Hearing as yet unpublished data from Dr William Skarnes of the Wellcome Trust Sanger Institute as part of our extensive line up of case studies from CRISPR pioneers



''This conference has been specifically designed to help industry professionals seize the true potential of this world-changing technology.''
Katherine Gordon, Conference Director, IQPC

"This is one of the best conferences I've attended in many years. Really good networking opportunities too."
TEVA

"This was a very comprehensive event and I felt it gave everyone a good opportunity to engage with each other at a 360-degree level."
ESP

Register at ASDEvents and receive 15% discount.

2015 Speakers Included:

  • Jonathan Gootenberg, Scientist, The Zhang Lab
  • Dr. Sam Sternberg, CRISPR Expert and Genome Engineer, The Doudna Lab
  • Dr. William Skarnes, Senior Group Leader, Wellcome Trust Sanger Institute
  • Dr. Jonathan Wrigley, Associate Director of Cellular Reagents & Assay Development, AstraZeneca
  • Dr. Steve Sheardown, Transgenic Group Head, Takeda Cambridge
  • Dr. Andrew Bassett, Postdoctoral Fellow, Genome Engineering Oxford
  • Dr. Joey Riepsaame, Postdoctoral Research, The Netherlands Cancer Institute
  • Dr. Fanny Decarpentrie, Postdoctoral Research Fellow, The Francis Crick Institute
  • Dr. Bhuvaneish.T. Selvaraj, Postdoctoral Fellow, Scottish Centre for Regenerative Medicine
  • Mark Sheehan, Biomedical Research Centre Ethics Fellow, Ethox Centre, University of Oxford
  • Dr Mick Fellows, Principal Scientist, AstraZeneca
  • Dr. Philippa Brice, External Affairs Director, PHG Foundation
  • Dr Robin Lovell-Badge, Head of the Division of Stem Cell Biology and Developmental Genetics, The Francis Crick Institute
  • Professor Gareth Bond, Associate Professor, Ludwig Institute for Cancer Research
  • Dr. Roderick Beijersbergen, Associate Professor, The Netherlands Cancer Institute
  • Dr. Andrew Wood, Chancellor's Fellow, Institute of Genetics and Molecular Medicine

Register at ASDEvents and receive 15% discount.

Please fill in your name and email to receive the registration policy of this event.

Venue

The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Venue

Venue to be confirmed
London, UK

Accommodation

More information to follow...

Please note: We will never recommend, approve or appoint any third party rooming service to act on our behalf. Please be extremely wary if you are approached by any such companies. We will always endeavour to negotiate the best available rates for you so please use the Hotel's website link provided.

Register at ASDEvents and receive 15% discount.
Event details
Organizer : IQEU
Event type : Conference
Reference : ASDE-15583